CME and CFTC Clash Over On-Chain Perpetual Futures

The Commodity Futures Trading Commission's decision to allow the listing of perpetual futures products on blockchain has sparked a heated dispute with the CME Group, the largest derivatives exchange operator in the US. The CME has filed a lawsuit against the CFTC, arguing that the regulator is misapplying the law by allowing products that do not have an end date, which is a key characteristic of traditional futures contracts. The dispute centers on the CFTC's approval of crypto perps, which are decentralized derivative contracts that enable users to speculate on the price of an asset with leverage and no expiration date. The CME claims that these products are harmful to its long-dated futures products and that the CFTC's sudden embrace of them did not consider the ramifications. The tension between the two entities has been escalating, with the CME attempting to fast-track 24/7 trading for crude oil futures, only to be blocked by the CFTC. The regulator has declined to comment on the matter, while the CME's chairman, Terry Duffy, has expressed concerns about the CFTC's approach, arguing that the definition of a swap is clear and that the CFTC is not following the protocol. The dispute has significant implications for the US approach to the rapidly growing arena of perpetual futures, with non-US perps volume reportedly reaching $60 trillion in volume last year. The CFTC's decision to allow the listing of perpetual futures products has been seen as a move to open up the US market, but the CME's lawsuit has thrown the future of CFTC-driven perps into uncertainty.